Registration discounts ending 6/12 for access to 2024's practice-changing cancer research. Get all the research highlights from this year's biggest oncology event!
- Program
What you'll learn at Best of ASCO®.
Access the program details here.
- Online Meeting Access
How to navigate the meeting.
Login assistance.
- Program
Suchergebnisse
Suchergebnisse:
The ICR is a UK charity and member institution of the University of London, conducting world-class cancer research and clinical trials. Learn about its PhD and postdoc opportunities, collaborations, appeals, and how to share your cancer story.
- Our Research
The Institute of Cancer Research, London, has been driving...
- Studying and Training
The Institute of Cancer Research, London, is the UK’s...
- Careers
As a world-leading research organisation, The Institute of...
- Working with Industry
The Institute of Cancer Research, London, has an unrivalled...
- About Us
The ICR is led by Chief Executive Professor Kristian Helin ,...
- Research divisions
Research at The Institute of Cancer Research is structured...
- Our Research
The ICR is a UK charity and member institution of the University of London, conducting world-class cancer research and clinical trials. Learn about its PhD and postdoc opportunities, collaborations, appeals, and how to share your cancer story.
The Institute of Cancer Research (the ICR) is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. [7]
Vor 4 Tagen · ASCO 2024: New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse. A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, London, has shown.
AI presents an unprecedented opportunity to advance our understanding cancer and improve care for people with cancer. Artificial intelligence (AI) is a machine’s ability to perform functions that are usually thought of as intelligent human behaviors, such as learning, reasoning, and solving problems. Computers derive this ability from ...
Docetaxel in patients with metastatic breast cancer: a phase II study of the National Cancer Institute of Canada Clinical Trials Group.